compar studi inhal atropin sulfat isoproterenol hydrochlorid cystic fibrosi investig contribut vagal tone obstruct airway diseas cystic fibrosi evalu pulmonari function respons administr 01 mg atropin sulfat per kg bodi weight 005 mg isoproterenol hydrochlorid per kg bodi weight isoton salin control solut administ nebul 3 differ day 10 patient cystic fibrosi singl blind studi dose atropin sulfat isoproterenol hydrochlorid base publish doserespons characterist drug day thorac ga volum airway resist measur volum displac bodi plethysmograph maxim expiratori flowvolum curv perform 15 30 60 min inhal inhal salin group mean valu pulmonari function indic greater airway obstruct 15 30 60 min compar pretreat valu inhal isoproterenol atropin signific improv p 005 note maxim expiratori flow 60 per cent total lung capac specif airway conduct thorac ga volum residu volum inhal atropin also significantli improv maxim expiratori flow 25 per cent vital capac isoproterenol increas mean flow 8 46 per cent baselin decreas thorac ga volum residu volum 11 16 per cent maxim respons 15 30 min atropin increas mean flow 15 77 per cent decreas thorac ga volum residu volum 16 25 per cent maxim effect 30 60 min mean respons atropin express percentag baselin alway greater equal isoproterenol conclud vagal tone may reflect increas irrit receptor activ contribut obstruct pulmonari function cystic fibrosi inhal atropin sulfat decreas pulmonari function abnorm side effect prohibit clinic use